Lyell Immunopharma (LYEL) Enterprise Value: 203.51M

Lyell Immunopharma, Inc. (LYEL)

15.43 +4.66 (+43.27%) USD | NASDAQ | Nov 04, 16:00

15.88 +0.45 (+2.92%) Pre-Market: 09:08

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2021. Start Trial.

Date	Value
November 04, 2026	203.51M
November 03, 2026	94.48M
November 02, 2026	97.06M
October 30, 2026	100.80M
October 29, 2026	107.00M
October 28, 2026	98.23M
October 27, 2026	79.27M
October 26, 2026	60.32M
October 23, 2026	62.19M
October 22, 2026	61.96M
October 21, 2026	62.66M
October 20, 2026	69.45M
October 19, 2026	48.39M
October 16, 2026	32.48M
October 15, 2026	34.12M
October 14, 2026	29.44M
October 13, 2026	18.21M
October 12, 2026	35.99M
October 09, 2026	46.28M
October 08, 2026	48.16M
October 07, 2026	42.77M
October 06, 2026	43.94M
October 05, 2026	54.71M
October 02, 2026	59.15M
October 01, 2026	62.66M

Date	Value
September 30, 2026	71.55M
September 29, 2026	67.81M
September 28, 2026	70.38M
September 25, 2026	72.96M
September 24, 2026	79.27M
September 23, 2026	88.87M
September 22, 2026	103.37M
September 21, 2026	98.23M
September 18, 2026	100.10M
September 17, 2026	95.18M
September 16, 2026	94.60M
September 15, 2026	97.76M
September 14, 2026	107.58M
September 11, 2026	122.32M
September 10, 2026	127.94M
September 09, 2026	143.85M
September 08, 2026	159.06M
September 04, 2026	178.71M
September 03, 2026	177.54M
September 02, 2026	192.40M
September 01, 2026	182.34M
August 31, 2026	177.54M
August 28, 2026	182.45M
August 27, 2026	184.33M
August 26, 2026	188.77M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks